The Zacks Analyst Blog Highlights: Apple, Eagle Bancorp Montana, Onconova Therapeutics, Proteostasis Therapeutics and Abeona Therapeutics

Zacks Equity Research
0

For Immediate Release

Chicago, IL – February 19, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Apple Inc. AAPL, Eagle Bancorp Montana, Inc. EBMT, Onconova Therapeutics, Inc. ONTX, Proteostasis Therapeutics, Inc. PTI and Abeona Therapeutics Inc. ABEO.

Here are highlights from Tuesday’s Analyst Blog:

Coronavirus to Hit Apple Sales:  Invest in Domestic Producers

Apple Inc. recently warned its investors of the impact of the deadly coronavirus outbreak on its business. Notably, the iPhone maker has been affected more than previously anticipated as the number of iPhones it can manufacture and sell in China will be limited. The iPhone maker announced that it is trimming sales expectations for this quarter. After all, demand for its products has declined in China, thanks to the outbreak.

Apple has closed all 42 of its stores in the country last month and many are yet to reopen. Management added that “we are experiencing a slower return to normal conditions than we had anticipated. As a result, we do not expect to meet the revenue guidance we provided for the March quarter.”

Needless to say, that the iPhone maker is heavily dependent on Chinese factories and consumers. Apple CEO, Tim Cook has been working with several Chinese telecom providers in introducing the iPhone in the country over the last 10 years. Following these committed initiatives, iPhone sales did take off, and now China is Apple’s second largest market after the United States.

By the way, Apple also assembles products in China. For instance, a Taiwanese company named Foxconn makes iPhones and other gadgets on behalf of Apple. However, concerns regarding the impact of coronavirus impact on the global economy and subsequently on corporate profits have been on the rise. The deadly virus has now infected over 72,000 people and claimed 1,800 lives, according to official reports. What’s more, nearly three-quarters of a billion people are already locked down in China, per a New York Times analysis.

Further, with the crisis deepening, not just Apple but a host of big companies have indicated that productions may be hurt, which in turn will have a bearing on their financial results. While Fiat Chrysler Automobiles has recently shut down several factory outlets in China, European aerospace giant Airbus, General Motors and Toyota have begun to limit production in China.

Starbucks and Ikea have shut down many stores, while deserted shopping malls in China are expected to adversely impact sales for retailers including Nike and others. Travel related stocks have been hit hard too. Notably, Lufthansa and British Airways have cancelled flights to China. To top it, after a recent breathtaking run, Tesla, Inc. (TSLA) is looking vulnerable following the coronavirus outbreak. The electronic car maker did acknowledge risks that the coronavirus threat poses to output and overall business.

Coronavirus Threat Escalates! Grab These 4 Stocks Now

With the coronavirus threat increasing, it’s quite evident that companies having significant exposure to China and the global economy are vulnerable. However, domestic producers of goods should remain unaffected. Due to their limited international exposure, they offer higher protection than their large- and mid-cap counterparts against any economic upheaval. These stocks also have solid growth narratives as their promising outlook remains unfazed by the coronavirus outbreak.

We have, thus, selected four such stocks that should make meaningful additions to your portfolio. These stocks flaunt a Zacks Rank #1 (Strong Buy) or 2 (Buy).

Eagle Bancorp Montana, Inc.operates as the bank holding company for Opportunity Bank of Montana that provides various retail banking products and services in Montana. The company, currently, has a Zacks Rank #2. The Zacks Consensus Estimate for its current year earnings increased 1% over the past 90 days. The company’s expected earnings growth rate for the current quarter and year are 9.1% and 6.2%, respectively.

Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule product candidates to treat cancer. Onconova Therapeutics was founded in 1998 and is headquartered in Newtown, PA. The company, currently, has a Zacks Rank #2. The Zacks Consensus Estimate for its current year earnings increased 42% over the past 60 days. The company’s expected earnings growth rate for the current quarter and year are 94.1% and 57.7%, respectively. You can see the complete list of today’s Zacks #1 Rank stocks here.

Proteostasis Therapeutics, Inc. engages in the discovery and development of various small molecule therapeutics to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing. Proteostasis Therapeutics was founded in 2006 and is headquartered in Boston, MA. The company, currently, has a Zacks Rank #1. The Zacks Consensus Estimate for its current year earnings increased 0.8% over the past 60 days. The company’s expected earnings growth rate for the current quarter and year are 19.4% and 25.5%, respectively.

Abeona Therapeutics Inc. develops cell and gene therapies for life-threatening rare genetic diseases. Abeona Therapeutics was incorporated in 1974 and is based in New York. The company, currently, has a Zacks Rank #2. The Zacks Consensus Estimate for its current year earnings increased 2.6% over the past 60 days. The company’s expected earnings growth rate for the current and next quarters are 19.4% and 30.8%, respectively.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%.

This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year.

See their latest picks free >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com                    

https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Apple Inc. (AAPL) : Free Stock Analysis Report
 
Eagle Bancorp Montana, Inc. (EBMT) : Free Stock Analysis Report
 
Abeona Therapeutics Inc. (ABEO) : Free Stock Analysis Report
 
Onconova Therapeutics, Inc. (ONTX) : Free Stock Analysis Report
 
Proteostasis Therapeutics, Inc. (PTI) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement

Recommended Stories

  • Dow Jones Falls As Donald Trump Stock Craters; Cathie Wood Buys This Stock Amid 51% Plunge

    The Dow Jones fell as Elon Musk made a Tesla move. The Donald Trump stock sank on the stock market today. Cathie Wood bought a diving stock.

  • Trump Media stock tanks on move to issue millions of shares

    Trump Media stock slid as much as 16% on Monday after the parent company of Donald Trump's social media platform, Truth Social, filed to issue more than 21 million shares.

  • Wall Street Selloff Goes Global Amid US Rate Angst: Markets Wrap

    (Bloomberg) -- A selloff on Wall Street went global as investors grappled with the threat of higher-for-longer interest rates, China’s sluggish economy and an Israeli counter-strike. Most Read from BloombergBeyond the Ivies: Surprise Winners in the List of Colleges With the Highest ROIIran’s Attack on Israel Sparks Race to Avert a Full-Blown WarApple Faces Worst iPhone Slump Since Covid as Rivals RiseIsrael Versus Iran — What All-Out War Could Look LikeTesla Executive Baglino Leaves as Musk Lose

  • 4 Oversold Stocks to Buy Right Now

    Here are four stocks to buy now that could offer investors upside in the short and long term.

  • Nvidia Reveals 8 'Secrets' For When To Sell Stocks. No. 2 Is Key.

    As top growth stocks like Nvidia test key moving averages, keep in mind these proven rules for when to sell stocks.

  • Tesla layoffs hit high performers, some departments slashed, sources say

    Tesla management told employees Monday that the recent layoffs -- which gutted some departments by 20% and even hit high performers -- were largely due to poor financial performance, a source familiar with the matter told TechCrunch. The layoffs were announced to staff just a week before Tesla is scheduled to report its first-quarter earnings. The move comes as Tesla has seen its profit margin narrow over the past several quarters, the result of an EV price war that has persisted for at least a year.

  • Elon Musk Agrees With Jamie Dimon's Warning Of Political Polarization 'Creating Risks That Could Eclipse Anything Since World War II'

    JP Morgan Chase & Co. (NYSE:JPM) CEO Jamie Dimon's annual shareholder letter is a moment investors await to understand the thinking of one of the world's most influential bankers. While there has been speculation of Dimon entering politics, with him even gaining the support of billionaire hedge fund manager Bill Ackman to run for president, JP Morgan shared in a statement that "Jamie has no plans to run for office" and that "he is very happy in his current role." That has not stopped him from oc

  • Not-So-Happy Meal: $20 Wages Has Burger Joints In This State All Heated

    California fast-food employees started earning a minimum of $20 an hour in April. Thanks to a new law, which went into effect earlier this month, California chain restaurants with at least 60 locations nationwide have to pay their employees more. For smaller restaurants, the minimum wage continues to be the statewide bottom of $16 an hour. The largest publicly-traded fast-food companies include McDonald’s Corp (NYSE:MCD); Starbucks Corp (NASDAQ:SBUX); Yum! Brands, Inc. (NYSE:YUM), which owns Tac

  • Xiaomi’s Success Means More Trouble for Battered China EV Stocks

    (Bloomberg) -- Xiaomi Corp.’s roaring entry into the electric vehicle market is dimming the recovery outlook for China’s beaten down auto startups.Most Read from BloombergBeyond the Ivies: Surprise Winners in the List of Colleges With the Highest ROIIran’s Attack on Israel Sparks Race to Avert a Full-Blown WarApple Faces Worst iPhone Slump Since Covid as Rivals RiseIsrael Versus Iran — What All-Out War Could Look LikeTesla Executive Baglino Leaves as Musk Loses Another Top DeputyHype around the

  • We're 66 With $1.4 Million in IRAs, and $4,100 Monthly From Social Security. What's Our Retirement Budget?

    Say that, as a married couple, you have $1.4 million in your IRAs and, at age 66, expect about $4,100 per month in Social Security. Based on some typical rules of thumb, you might be able to plan on about $108,000 per year of retirement income, but how much you actually need and will be […] The post We're 66 With $1.4 Million in IRAs, and $4,100 Monthly From Social Security. What's Our Retirement Budget? appeared first on SmartReads by SmartAsset.